GenKyoTex
ExitedLeader in NOX therapies;based on the selective inhibition of NOX enzymes
GenKyoTex has raised €55M across 5 funding rounds from 3 investors, most recently a Series D+ round in Jan 2015. Based in Plan-les-Ouates, Switzerland; founded 2006; active in Healthtech. Acquired by Calliditas Therapeutics in 2014. Data as of 28 Oct 2026.
Total raised
€55M
€55,435,398
Funding rounds
5
Investors
3
distinct backers
Active since
2006-01
latest 2015-01
Funding by year
EUR raised per yearGenKyoTex — funding by year — interactive chart.
Data table
| GenKyoTex — funding by year | |
|---|---|
| 2005 | €1.3M |
| 2008 | €2.4M |
| 2011 | €14M |
| 2012 | €21M |
| 2014 | €17M |
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-01-01 | Series D+ | €17M | BioMedPartners,VI Partners | View deal → |
| 2012-07-01 | Series C | €21M | MP Healthcare Venture Management | View deal → |
| 2011-05-01 | Series C | €14M | MP Healthcare Venture Management | View deal → |
| 2008-05-01 | Early VC | €2.4M | — | View deal → |
| 2006-01-01 | Early VC | €1.3M | — | View deal → |
Exit
Type
acquisition
Date
Nov 2014
Value
€16M
Acquiror
Calliditas Therapeutics (Sweden)
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData